Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion

Pflugers Archiv European Journal of Physiology

Volumn 464, Issue 5, 2012, Pages 513-522

  King, Nicola ^a   Al Shaama, Madj ^b   Suleiman, M Saadeh ^b  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ischaemia reperfusion; Myocardial hypertrophy; Myocardial protection; Propofol

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; PROPOFOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CONVALESCENCE; HEART HYPERTROPHY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART PROTECTION; HEART STROKE VOLUME; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

ANIMALS; CARDIAC OUTPUT; CARDIOMEGALY; MYOCARDIAL REPERFUSION; MYOCYTES, CARDIAC; NAD; PROPOFOL; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STROKE VOLUME;

EID: 84867877088     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-012-1152-5     Document Type: Article

References (30)

1. Afanas'ev I (2011) ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Med Cell Longev. doi:10.115/2011/293769
2. Allard MF (2004) Energy metabolism in cardiac hypertrophy. Curr Hypertens Rep 6:430-435
3. Brooksby P, Levi A, Jones JV (1993) The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens 11:611-622
4. Corcoran TB, Sakamoto AEH, O'Shea A, O'Callaghan-Enright S, Shorten GD (2006) The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 97:825-831
5. Friddle CJ, Koga T, Rubin EM, Rubin J (2000) Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 97:6745-6750
6. Garcia-Dorado D (2004) Myocardial reperfusion injury: a new view. Cardiovasc Res 61:363-364
7. Green TR, Bennett SR, Nelson VM (1994) Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 129:163-169
8. 2-induced autophagic cell death by propofol in H9c2 cardiomyocytes. Cell Biol Toxicol 28:19-29
9. Hochhauser E, Lesham D, Kaminski O, Cheporko Y, Vidne BA, Shainberg A (2007) The protective effect of prior ischaemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart. Interact Cardiovasc Thorac Surg 6:363-368
10. Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman M-S (2001) Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circ 103:1551-1556
11. Javadov SA, Lim KHH, Kerr PM, Suleiman M-S, Angelini GD, Halestrap AP (2000) Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360-369
12. Kamada N, Kanaya N, Hirata N, Kimura S, Namiki A (2008) Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3β. Can J Anesth 55:595-605
13. King N, Lin H, McGivan JD, Suleiman M-S (2004) Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury. J Physiol 556:849-858
14. King N, Lin H, McGivan JD, Suleiman M-S (2006) Expression and activity of the glutamate transporter EAAT2 in cardiac hypertrophy: implications for ischaemia reperfusion injury. Pflügers Arch 452:674-682
15. Li YC, Ridefelt P, Wiklund L, Bjerneroth G (1997) Propofol induces a lowering of free cytosolic calcium in myocardial cells. Acta Anaesth Scand 41:633-638
16. Lim KHH, Halestrap AP, Angelini GD, Suleiman M-S (2005) Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med 230:413-420
17. Pantos C, Mourouzis I, Colekinos DV (2007) Protection of the abnormal heart. Heart Fail Rev 12:319-330
18. Shao H, Li J, Zhou Y, Ge Z, Fan J, Shao Z, Zeng Y (2008) Dosedependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br J Pharmacol 153:1641-1649
19. 2+ and voltage-activated potassium channels. J Pharmacol Exp Ther 330:727-735
20. Stekiel TA, Contney SJ, Roman RJ, Weber CA, Stadnicka A, Bosnjak ZJ, Greene AS, Moreno C (2011) Pharmacogenomic strain differences in cardiovascular sensitivity to propofol. Anesthesiol 115:1192-1200
21. Stekiel TA,Weber CA, Contney SJ, Bosnjak ZJ (2007) Differences in cardiovascular sensitivity to propofol in a chromosome substitution rat model. Croat Med J 48:312-318
22. Suleiman M-S, Caputo M, Ascione R, Bryan AJ, Lucchetti V, Gomes WJ, Angelini GD (1998) Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease. J Mol Cell Cardiol 30:2519-5223
23. Suleiman M-S, Hancock M, Shukla R, Rajakaruna C, Angelini GD (2011) Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery. Perfusion 26:48-56
24. Tao X, Lu L-Q, Xu Q, Li S-R, Lin M-T (2009) Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusion injury: propofol versus isoflurane. J Zhejiang Univ Sci B 10:740-747
25. Venturini A, Ascione R, Lin H, Polesel E, Angelini GD, Suleiman M-S (2009) The importance of myocardial amino acids during ischemia and reperfusion in dilated left ventricle of patients with degenerative mitral valve disease. Mol Cell Biochem 330:63-70
26. Williams H, King N, Griffiths EJ, Suleiman M-S (2001) Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes. Cardiovasc Res 33:2109-2119
27. Xia ZY, Godin DV, Ansley DM (2003) Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F-2 t-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 59:113-121
28. Xia ZY, Luo T (2004) Sevoflurane or desflurane anesthesia plus postoperative propofol sedation attenuates myocardial injury after coronary surgery in elderly high-risk patients. Anesthesiol 100:1038-1039
29. Xia W-F, Liu Y, Zhou Q-S, Tang Q-Z, Zou H-D (2011) Comparison of the effects of propofol and midazolam on inflammation and oxidative stress in children with congenital heart disease undergoing cardiac surgery. Yonsei Med J 52:326-332
30. Xia W-F, Liu Y, Zhou Q-S, Tang Q-Z, Zou H-D (2011) Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Cardiol 32:940-946